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Introduction
Four acetylcholinesterase inhibitors have received approval 
for clinical use in early- to mid-stage Alzheimer’s disease: 
tacrine, donepezil, rivastigmine and galanthamine. tacrine was 
the first to gain FDA approval in 1993 but has been largely 
withdrawn due to adverse side effects. the three remaining 
drugs, donepezil, rivastigmine and galanthamine, have fewer 
adverse side-effects and appear relatively safe for general use 
(50).
Galanthamine, an Amaryllidaceae type alkaloid, is a long 
acting, selective, reversible and competitive Ache inhibitor 
(35), which is marketed as a hydrobromide salt under the 
name of Razadine® (formerly Reminyl®) and nivalin® for 
the treatment of Alzheimer’s disease, poliomyelitis and other 
neurological diseases (25). After its discovery in 1952 by 
Proskurina and Yakovleva in Galanthus woronowii (39, 40), the 
pharmacological properties of galanthamine soon attracted the 
attention of the pharmaceutical industry. It was first produced 
by Sopharma (Bulgaria) under the name of nivalin®. G. nivalis 
plants were used in the early 1960s for industrial extraction 
but due to their small size and variability of galanthamine 
content, this species was soon replaced by the considerably 
bigger L. aestivum (49). Galanthamine has been found in 
many plants from the genera Amaryllis, Hippeastrum, Lycoris, 
Ungernia, Leucojum, Narcissus, Galanthus, Zephyranthes, 
Hymenocallis, and Haemanthus (15). It is currently being 
extracted from daffodils (Narcissus cultivars) in central and 
west Europe, snowflake (Leucojum aestivum) in east europe, 
‘red-tubed lily’ (Lycoris radiata) in china, and Ungernia 
victoria in Uzbekistan and Kazakhstan.
Although the chemical synthesis of galanthamine has been 
successfully achieved (19), plants remain the main source of 
this important natural product. Due to the increased demand for 
galanthamine and the limited availability of plant sources, in 
vitro culture of galanthamine-producing species has attracted 
the attention of researchers as an alternative approach for its 
sustainable production (17, 38).
During the past 30 years considerable efforts have been 
made to establish in vitro production of secondary plant 
metabolites, mainly using undifferentiated callus or suspension 
cell cultures that allow scale-up in bioreactors. however, 
commercial success has been very limited mainly because most 
secondary metabolites are produced only in very low amounts 
in undifferentiated cells: moreover, the production capacity of 
cell lines often declines over time or during scale-up (12).
the production cost of galanthamine is determined by 
the quality of plant row materials, namely their galanthamine 
content and its percentage in the alkaloid mixtures. these 
phytochemical characteristics of the plant sources influence 
the efficiency of extraction technology and therefore the 
production costs. other galanthamine type alkaloids such as 
narwedine or N-demethylgalanthamine are of interest since 
they could be used as precursors for galanthamine synthesis.
this article aims to provide a brief overview of the 
phytochemical and biotechnological studies of the current 
plant sources of galanthamine as well as some future prospects 
for its production from natural sources.
Leucojum aestivum
Leucojum aestivum L. (snowflake) is a plant species distributed 
in the Mediterranean region and eastern europe. the leaves are 
30–60 cm long and the bulb 2–4 cm in diameter. It is currently 
used for the extraction of galanthamine, mainly under licence 
in Bulgaria. it is gathered from natural habitats, which is 
causing problems with depletion of wild populations. A 
plantation of L. aestivum has been created in Bulgaria to supply 
the industry with leaf biomass, which is used for extraction. 
The galanthamine content in the leaves, referred to DW, was 
Plant sources of galanthamIne: PhytochemIcal and 
bIotechnologIcal asPects
S. Berkov1, l. Georgieva2, V. Kondakova2, A. Atanassov2, F. Viladomat1, J. Bastida1, c. codina1
University of Barcelona, Faculty of Pharmacy, Department of Natural Products, Plant Biology and Soil Science, Barcelona, 
Spain1
AgroBioInstitute, Sofia, Bulgaria2
correspondence to: Violeta Kondakova
e-mail: violeta.kondakova@gmail.com
abstract
Galanthamine, an Amaryllidaceae type alkaloid, is an AChE inhibitor marketed as a hydrobromide salt for the treatment of 
Alzheimer’s disease, poliomyelitis and other neurological diseases. Although the chemical synthesis of galanthamine has been 
successfully performed, plants are the main source of its production. The phytochemical and biotechnological aspects of plants 
currently used for galanthamine production, namely Leucojum aestivum, Narcissus ssp. Ungernia victoris and Lycoris radiata, 
are summarized in the present paper.


































































fig. 1. Phenolic oxidative coupling of O-methylnorbelladine in the biosynthesis of Amaryllidaceae alkaloids.
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found to vary from trace amounts to 0.5% (generally 0.1-0.3%) 
depending on the geographical location of the populations 
(46). The alkaloid synthesis of L. aestivum populations can 
be dominated by different skeleton types (galanthamine, 
lycorine, homolycorine and haemanthamine) in relation to 
their origin (22, 46), reflecting the quality of the plant material. 
South-east Bulgarian populations of snowflake were found to 
be the richest in galanthamine, dominated by galanthamine 
type synthesis (46). In contrast, plants collected in Romania 
were dominated by lycorine type compounds, yielding 0.26% 
of lycorine and 0.19% of galanthamine (referred to DW) 
(23). Phytochemical studies have revealed the occurrence of 
about 36 alkaloids in the alkaloid mixtures of L. aestivum (5, 
9, 10, 13, 22, 29, 30, 41, 42, 46; table 1), which also show 
geographical variations in their distribution. As an example, 
leucotamine and methylleucotamine (29), two galanthamine 
type alkaloids, were isolated from plants grown in Japan, but 
they were not detected in plants collected in Bulgaria (9, 22, 
46). Apart from galanthamine, three other alkaloids with a 
higher Ache inhibitory activity than galanthamine, namely 
sanguinine, N-allylnorgalanthamine and N-(14-methylallyl)
norgalanthamine, have been isolated from snowflake (10, 13, 
22). the percentage of galanthamine in the alkaloid mixture of 
leaves was reported for one population (12%) (9). Galanthamine 
was found to vary from 4 to 99 % of all compounds in the 
alkaloid mixtures of dormant bulbs from eighteen Bulgarian 
populations (22).
Narcissus ssp.
Bulbs of Narcissus plants are used as material for extraction 
of galanthamine. More than one hundred cultivars and different 
species of Narcissus have been screened for this alkaloid, 33 
of them having showed more than 0.1% (referred to DW) 
of galanthamine in their bulbs (16). The cultivar ‘Favourite’ 
was found to accumulate 0.15% of galanthamine. Another 
promising cultivar,  ‘Ice Follies’, was reported to yield 70 mg 
of galanthamine from 100g of DW (36). The main commercial 
source of galanthamine, however, is N. pseudonarcissus cv. 
‘carlton’ due to its bulb size (4-5 cm in diameter) and high 
galanthamine content, which is about 0.10-0.13 % (32). It is 
commercially cultivated in the UK and netherlands by various 
bulb growers.
Despite intensive phytochemical investigations, data on 
the proportion of galanthamine (and the other alkaloids) in 
the crude alkaloid mixtures of Narcissus cultivars are scarce. 
Kreh et al. (33) reported 58 % of galanthamine in a bulb 
alkaloid mixture from N. pseudonarcissus cv. ‘carlton’ based 
on a Gc-MS study. these authors also reported 23 alkaloids 
of galanthamine, lycorine, homolycorine and haemanthamine 
types in the bulbs of this cultivar (table 1). overall, more than 
one hundred alkaloids have been found in plants of the genus 
Narcissus (7).
one of the most promising species for cultivation is 
N. confusus - an endemic plant found only in Spain, which 
has been found to contain around 0.6 % (referred to DW) 
of galanthamine (6). In a preliminary assay with plants 
transferred to a greenhouse, the alkaloid pattern of N. confusus 
was studied throughout its phenological cycle (34). What 
is most interesting in this plant species is the high level of 
galanthamine accumulated in the total aerial parts of the plant 
(leaves, stems and flowers) at the end of the ontogenic cycle, 
which can reach up to 2.5 % referred to DW.
Ungernia victoris
Ungernia victoris Vved. is an endemic plant that is widespread 
only on the Gissar Ridge and its southern spurs (tadzhikistan 
and Uzbekistan). it is a perennial species with leaves up to 20-
25 cm long and bulbs 4-7 cm in diameter (47). This plant has 
been cultivated since 1970 in locations near its natural habitats. 
the leaves and bulbs have been used as a plant raw material for 
galanthamine extraction since 1960 (52). The total alkaloids in 
the leaves and bulbs were found to be 0.27-0.71% and 1.18-
1.65 % of DW, respectively. The proportion of galanthamine 
in the alkaloid mixtures was around 56-57% and 47-48% in 
the foliage and bulbs, respectively (43). its accumulation, 
depending on growing conditions (5), reached up to 0.52% 
of DW in cultivated plants, which yielded 20-25% more leaf 
mass compared to wild populations (27). About 10 alkaloids 
have been reported in this plant species (1, 2, 3, 43, 51, 53; 
table 1).
Lycoris radiata
Lycoris radiata Grey is a plant species distributed in china, 
Japan and Korea. The bulbs are 1-3 cm in diameter, while 
the leaves are up to 50 cm long. two varieties of L. radiata 
have been described: var. pumila which has a diploid genome, 
and var. radiata, with a triploid genome (24). Despite the 
high amount of work, found by SciFinder ScholartM 2007 
(American Chemical Society; accessed November 2008), 
mainly in chinese journals, it was not possible to obtain 
information on the galanthamine content of this plant species. 
twenty-two alkaloids have been reported to occur in L. radiata 
(11, 14, 26, 28, 31, 37, 48; table 1). Since 2002, this plant has 
been cultivated in china for galanthamine extraction (http://
www.galanthamine.cn/plantation.php).
In vitro production of galanthamine
only two plant species have been studied for their in vitro 
galanthamine production, N. confusus and L. aestivum. callus 
induction is a key point both for micro-propagation and 
obtaining different methods for alkaloid production. however, 
the degree of cell and tissue differentiation, strongly influences 
the galanthamine content in these two species (38, 44), and 
the lowest levels of galanthamine have been found in calli: 12 
ug/g for L aestivum and 0.03 ug/g for N. confusus both referred 
to dry weight. As shoot-clump cultures have a higher ability 
to synthesise this compound, they have been used as a model 
system for studies on in vitro galanthamine production (8, 9, 38, 
44, 45). the galanthamine content in shoot-clumps was found 
to vary when the cultures were cultivated on nutrient media 
with different combinations of phytohormones (20). content 
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Galanthamine (1) + + + +
Galanhamine-N-oxide (2) +
epigalanthamine (3) + +




narwedine (8) + + +
lycoramine (9) + + +









lycorine (18) + + +
Ungiminorine (19) +
3-O-Acetylungiminorine (20) +









Ungerine (29) + +
Ungeridine (30) +
homolycorine (31) + + +
8-O-Demethylhomolycorine (32) + +
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of galanthamine also varied in shoot-clumps grown on a sole 
nutrient medium but induced from different wild populations 
(22) or calli (38). It was found that the light increases the 
galanthamine synthesis in a shoot-clump of L. aestivum 
cultivated in a liquid medium (38). Galanthamine content in L. 
aestivum shoot-clumps ranges from traces to 0.5 mg/g of DW 
(22, 38) and up to 2.5 mg per culture of N. confusus, of which 
1.97 mg is released into the medium (8). The galanthamine 
proportion in alkaloid mixtures of L. aestivum shoot-clumps 
varies greatly among different lines, sometimes consisting 
almost 100 %. Another major alkaloid in L. aestivum shoot-
clumps, lycorine, can reach up to 77% of total alkaloids (9, 
22). Recently initiated bioreactor experiments have shown 
a galanthamine yield of 2.5 mg/L (38). Increase of sucrose 
concentration (44) and addition of biotic elicitors (18) resulted 
in a ca. 300% increase of the galanthamine content in N. 
confusus shoot-clumps. transgenic cultures of L. aestivum 
have been successfully obtained, but galanthamine was not 
found in them (20).
conclusions
the introduction of new cultivars with a high galanthamine 
content and the development of biotechnologies both for in 
vitro production and crop improvement are highly desirable for 
homolycorine-N-oxide (33) +
lycorenine (34) +












Vittatine (46) + + +
11-Hydroxyvittatine (47) +
haemanthamine (48) + +
11-Oxohaemanthamine (49) +
8-O-Demethylmaritidine (50) + +
haemanthidine (51) + +
Tazettine type
Pretazettine (52) + +






hordenine (57) + +
Methyltyramine (58) +
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pharmaceutical companies to increase their competitiveness in 
the market. Although european and Asian amaryllidaceous 
plants are relatively well studied, the highest level of 
biodiversity in the Amaryllidaceae family is found in South 
America and South Africa, where the plants have scarcely been 
studied. the phytochemical investigations of plants used for 
galanthamine extraction have revealed complex and variable 
alkaloid patterns, which may be used to control the plant source 
of galanthamine substances. the introduction of crops with a 
higher proportion of galanthamine in the alkaloid mixtures 
is also of interest because it will facilitate the isolation and 
purification of this compound and could reduce the extraction 
costs. in this respect, genetic manipulation of the biosynthetic 
pathway leading to products coming from para-orto’ oxidative 
coupling of O-methylnorbelladine (fig. 1) in both crops 
and in vitro cultures is still an unexplored field. The in vitro 
studies of galanthamine synthesis are in their initial stages. 
the introduction of other galanthamine-producing species and 
selection of galanthamine-rich genotypes should be performed 
together with optimization of conditions for in vitro bioreactor 
cultivation.
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